ArticleAmerican journal of translational research2026
Short-term clinical remission rates and adverse reactions of rituximab compared to cyclosporine in patients with refractory membranous nephropathy (MN).
Biqing Fang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.